Share This
Teriparatide
Teriparatide (Forteo) is a recombinant form of parathyroid hormone, used in the treatment of some forms of osteoporosis. It is manufactured and marketed by Eli Lilly and Company.
Teriparatide is administered by injection once a day in the thigh or abdomen. The recommended dose is 20 μg per day....
Learn more about Teriparatide »
Add More Topics
Save this view to a base, or just for yourself.
3 Disease or medical condition topics matching:
Filter this Collection
+
Osteoporosis
Osteoporosis is a disease of bone that leads to an increased risk of fracture. In osteoporosis the bone mineral density (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of proteins in bone is altered. Osteoporosis is...
Associated medical specialties:
View entire collection »Treatments:
- Teriparatide ,
- Selective estrogen receptor modulator ,
- Hormone replacement therapy ,
- Strontium ranelate
Prevention factors:
Causes:
Hypoparathyroidism
In medicine (endocrinology), hypoparathyroidism is decreased function of the parathyroid glands, leading to decreased levels of parathyroid hormone (PTH). The consequence, hypocalcaemia, is a serious medical condition.
Additional symptoms that may...
Parent Disease:
Osteogenesis imperfecta
Osteogenesis imperfecta (OI and sometimes known as Brittle Bone Disease, or "Lobstein syndrome") is a genetic bone disorder. People with OI are born with defective connective tissue, or without the ability to make it, usually because of a deficiency...
